Subscribe To
Medivir hosts expert perspectives webcast on the evolving treatment landscape and the unique treatment challenges in hcc
STOCKHOLM , Sept. 1, 2023 /PRNewswire/ -- Medivir AB (NASDAQ Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments fo...
September 1, 2023, 3:20 am
23andme stock rallies more than 23% after genetics company gets ok to report more cancer risks
Shares of 23andMe Holding Co. ME, -4.35% jumped 23% in the extended session Thursday after the genetics and biopharmaceutical company said that the U....
August 31, 2023, 5:49 pm
Apollomics: a taiwanese-origin company with late stage pipeline
Apollomics is a small company with a pipeline of c-Met targeting small molecule TKIs for various cancers...
August 29, 2023, 6:21 am
Bridgebio pharma to present detailed results from the phase 3 attribute study in patients with transthyretin amyloidosis cardiomyopathy (attr-cm) at european society of cardiology (esc) congress 2023
PALO ALTO, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage...
August 24, 2023, 4:01 pm
Enliven therapeutics: preclinical company with interesting value proposition
Enliven Therapeutics, Inc. is a recently merged biopharma company focused on developing oncology candidates for leukemia and lymphoma. The company has...
August 18, 2023, 12:57 pm
Alpha tau announces robust long-term safety and efficacy data from multiple clinical trials of alpha dart
– 81 lesions treated across four feasibility trials of head and neck or skin cancers demonstrated 89%...
August 17, 2023, 9:00 pm
Where will exact sciences be in 5 years?
Exact Sciences has the potential to be a big name in cancer testing and screening in the future. It already has multiple tests, and is working on one ...
August 10, 2023, 9:37 am
Hillstream biopharma to present at the sidoti micro-cap virtual conference on august 16-17, 2023
BRIDGEWATER, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) ("Hillstream" or the "Company"), a biotechnology compan...
August 9, 2023, 8:47 am
Plus therapeutics to announce second quarter 2023 financial results and host conference call on august 14, 2023
AUSTIN, Texas, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company ...
August 8, 2023, 4:05 pm
Intensity therapeutics to announce financial results for the second quarter ended june 30, 2023, and provide corporate update
Webcast to be Held at 8:00 am ET on Monday, August 14, 2023 WESTPORT, Conn. , Aug. 7, 2023 /PRNewswire/ -- Intensity Therapeutics, Inc. (Intensity) (N...
August 7, 2023, 7:01 am
Plus therapeutics to present at the canaccord genuity 43rd annual growth conference
AUSTIN, Texas, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company ...
August 3, 2023, 7:00 am
Omega therapeutics: working in epigenetic anti-cancer programs
OMGA has an early stage program targeting various cancers using epigenetics. They are backed by a VC an...
August 1, 2023, 4:29 pm
Revolutin medicines to acquire eqrx in deal that will add $1 billion in cash to its balance sheet to fund r&d
Revolution Medicines Inc. RVMD, +2.10% said Tuesday it has reached a definitive agreement to acquire EQRx Inc. EQRX, in an all-cash deal that's expect...
August 1, 2023, 7:43 am
Bicycle therapeutics: decent upside opportunity, mid-stage data readouts due
Bicycle Therapeutics is an intriguing play in the drug development space. Using its fully synthetic short peptides, the company has developed two mid-...
July 31, 2023, 7:07 pm
Fda grants fast track designation to ivs-3001, a car-t cell therapy in the treatment of renal cell carcinoma
Houston, TX, USA, July 31, 2023 (GLOBE NEWSWIRE) — Invectys, Inc., a clinical-stage immuno-oncology company focused on developing novel therapies fo...
July 31, 2023, 10:00 am
Qualigen therapeutics divests fastpack® diagnostics business
All cash deal with Chembio Diagnostics, a US Subsidiary of the French Diagnostics Company BIOSYNEX, SA, solidifies Qualigen’s strategic priority on ...
July 24, 2023, 12:15 pm
Nanobiotix surges on commercialization deal with j&j's janssen for cancer therapeutic
French biotechnology company Nanobiotix has entered into an agreement with J&J's wholly-owned medical research and pharmaceutical arm Janssen to licen...
July 10, 2023, 1:11 pm
Genprex granted chinese patent for lead drug candidate reqorsa with pd-1 antibodies to treat cancers
Genprex Inc. revealed that the China National Intellectual Property Administration has granted it a broad patent, which covers the use of its lead dru...
July 5, 2023, 9:47 am
Black diamond therapeutics announces pricing of public offering of common stock
CAMBRIDGE, Mass and NEW YORK, June 29, 2023 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology ...
June 30, 2023, 12:57 am
Quest diagnostics' (dgx) new buyout expands cancer portfolio
Quest Diagnostics (DGX) will use MRD technology to create new blood-based clinical lab services for solid tumour ...
June 22, 2023, 2:06 pm